Back to search

Peptide record

TPDB08668

Antibacterial Anticancer Toxicity standard
17 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB08668
Antibacterial Anticancer Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 Peptipedia
standard
No
A 17-aa standard natural multi-activity (Antibacterial, Anticancer, and Toxicity) peptide sequence curated from AntiBP3 and Peptipedia, with an available 3D structural model.
Sequence
RFRRFRLPFRRPPIRIH
Physicochemical Analysis
C108H174N40O18
ANDCEQGKMSTWYV
R
2320.83
13.18
8
0
6
+7
3.41
-1.076
68.82
Mammalian: 1 hour Yeast: 2 min E.coli: 2 min
0
0.00
0
Residue Composition
number
0
A
7
R
0
N
0
D
0
C
0
E
0
Q
0
G
1
H
2
I
1
L
0
K
0
M
3
F
3
P
0
S
0
T
0
W
0
Y
0
V
Amino Acid Distribution
A: 0 R: 7 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 0 H: 1 I: 2 L: 1 K: 0 M: 0 F: 3 P: 3 S: 0 T: 0 W: 0 Y: 0 V: 0
Chemical Descriptors
17
C108H174N40O18
2320.83
13.18
+7
3.41
-1.076
Evidence Records 3 records
Evidence 1 Activity

Activity

50% Cytotoxicity
Toxicity
>64 µM
Cytotoxic
50% Cytotoxicity | >64 | µM | target cell: Human PBMC

Target

Human PBMC

Source & Reference

NA
DBAASP
Caprine Bactenecins as Promising Tools for Developing New Antimicrobial and Antitumor Drugs. | Front Cell Infect Microbiol | 2020
Evidence 2 Activity

Activity

<5% Hemolysis
Toxicity
64 µM
Hemolytic Cytotoxic
<5% Hemolysis | 64 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Caprine Bactenecins as Promising Tools for Developing New Antimicrobial and Antitumor Drugs. | Front Cell Infect Microbiol | 2020
Evidence 3 Activity

Activity

IC50
Toxicity
64 µM
Hemolytic Cytotoxic
Hemolytic_activity: Human erythrocytes: <5% Hemolysis=64 µM | Cytotoxicity: Human PBMC: IC50>64 µM

Target

erythrocytes

Source & Reference

NA
DRAMP
Front Cell Infect Microbiol. 2020 Oct 19 10:552905.